Related Experiment Video
Updated: Mar 29, 2026

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
COX-2 gene variants in bipolar disorder-I
Abdullah Ozdemircan1, Selcuk Dasdemir, Cem Ismail Kucukali
1Department of Molecular Medicine, Institute for Experimental Medicine Research, Istanbul University, Vakif Gureba Cad. Capa 34390, Istanbul, Turkey.
Genetic variants in the COX-2 gene are linked to bipolar I disorder (BD-I). Specifically, the COX-2-1195A→G AA genotype appears to facilitate BD-I development, while the G+ genotype may offer protection.
Area of Science:
- Genetics
- Psychiatry
- Molecular Biology
Background:
- Bipolar I disorder (BD-I) pathogenesis involves complex genetic and environmental factors.
- Studies indicate a link between BD-I and inflammation via shared genetic polymorphisms and altered cytokine levels.
- COX-2 gene variations may influence inflammatory responses, potentially impacting BD-I susceptibility.
Purpose of the Study:
- To investigate the association between COX-2 gene polymorphisms (COX-2-765G→C and COX-2-1195A→G) and bipolar I disorder.
- To explore the potential role of these genetic variants in the inflammatory pathways implicated in BD-I.
Main Methods:
- Genotyping of COX-2-765G→C and COX-2-1195A→G polymorphisms using PCR-RFLP.
- Analysis of 180 patients with bipolar I disorder and 170 healthy controls.
- Statistical comparison of genotype and allele frequencies between patient and control groups.
Main Results:
- A significant association was found between COX-2 gene variants and the development of BD-I.
- Statistically significant differences in COX-2-1195A→G genotypes and alleles were observed between controls and BD-I patients (p<0.000).
- The COX-2-1195A→G AA genotype showed a significant association with BD-I (p<0.000).
Conclusions:
- The COX-2-1195A→G AA genotype may facilitate the development of bipolar I disorder.
- A protective role against BD-I was suggested for the COX-2-1195A→G G+ genotype (p<0.000).
- Weak linkage disequilibrium was noted between COX-2-765G→C and COX-2-1195A→G polymorphisms.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Bipolar Disorder
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Pleiotropy
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

